Germline Testing of Patients With Non-small Cell Lung Cancers Demonstrating Incidentally Uncovered BRCA2 Apparent Pathogenic Germline Variants. Sorscher S. Clin Lung Cancer 2022;23:e405-e407.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sorscher S. Germline Testing of Patients With Non-small Cell Lung Cancers Demonstrating Incidentally Uncovered BRCA2 Apparent Pathogenic Germline Variants. Clin Lung Cancer 2022;23:e405-e407.
PMID: 35977876